WA
Wasatch Advisors’s Dyne Therapeutics DYN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.31M | Buy |
557,937
+46,889
| +9% | +$446K | 0.03% | 188 |
|
2025
Q1 | $5.35M | Buy |
511,048
+190,422
| +59% | +$1.99M | 0.03% | 184 |
|
2024
Q4 | $7.55M | Sell |
320,626
-3,473
| -1% | -$81.8K | 0.04% | 173 |
|
2024
Q3 | $11.6M | Sell |
324,099
-11,516
| -3% | -$414K | 0.06% | 150 |
|
2024
Q2 | $11.8M | Sell |
335,615
-82,179
| -20% | -$2.9M | 0.06% | 144 |
|
2024
Q1 | $11.9M | Sell |
417,794
-1,266,723
| -75% | -$36M | 0.06% | 154 |
|
2023
Q4 | $22.4M | Sell |
1,684,517
-3,285
| -0.2% | -$43.7K | 0.12% | 121 |
|
2023
Q3 | $15.1M | Sell |
1,687,802
-571,733
| -25% | -$5.12M | 0.1% | 128 |
|
2023
Q2 | $25.4M | Sell |
2,259,535
-667,743
| -23% | -$7.51M | 0.15% | 111 |
|
2023
Q1 | $33.7M | Buy |
2,927,278
+407,699
| +16% | +$4.7M | 0.21% | 92 |
|
2022
Q4 | $29.2M | Buy |
2,519,579
+227,311
| +10% | +$2.63M | 0.2% | 99 |
|
2022
Q3 | $29.1M | Buy |
+2,292,268
| New | +$29.1M | 0.2% | 106 |
|